1 0
Cart
    Inquiry
    Popular Searches: Recombinant Antibody MHC Tetramer T cell Receptor Scaffold Protein
    + Filter
    Loading...
    Custom Services order now ship next day

    EGFR & HER2

    Loading...

    Anti-EGFR & HER2 Products

    • Cetuximab (Gly-015CL)
      • CAS number: 205923-56-4
      Go to compare Compare
    • Anti-EGFR-MC-VC-PABA-MMAE ADC (ADC-037CL)
      • Target: EGFR
      • Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
      • Drug: MMAE (Monomethyl auristatin E)
      Go to compare Compare
    • Anti-EGFR-MC-VC-PABA-MMAE ADC (ADC-038CL)
      • Target: EGFR
      • Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
      • Drug: MMAE (Monomethyl auristatin E)
      Go to compare Compare
    • Anti-EGFR-mc-MMAF ADC (ADC-039CL)
      • Target: EGFR
      • Linker: Mc (maleimidocaproyl)
      • Drug: MMAF (Monomethyl auristatin F)
      Go to compare Compare
    • Anti-EGFR-vc-PAB-MODO ADC (ADC-263CL)
      • Target: epidermal growth factor receptor (EGFR)
      • Linker: VC-PAB (valine-citrulline-p-aminobenzoyloxycarbonyl)
      • Drug: MODO (monomethyldolastatin)
      Go to compare Compare
    • Anti-EGFR (clone J2898A)-SMCC-DM1 ADC (ADC-047LZY)
      • Target: EGFR
      • Linker: SMCC (N-succinimidyl-4-(N-maleimidomethyl)-cyclohexane-1-carboxylate)
      • Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
      Go to compare Compare
    • Anti-EGFR (MAb806)-SMCC-DM1 ADC (ADC-110LCT)
      • Target: EGFR variant III
      • Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
      • Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
      Go to compare Compare
    • Anti-EGFRvIII-SMCC-DM1 ADC (ADC-048LZY)
      • Target: EGFRvIII
      • Linker: SMCC (N-succinimidyl-4-(N-maleimidomethyl)-cyclohexane-1-carboxylate)
      • Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
      Go to compare Compare
    • Anti-EGFR-MCC-Dox ADC (ADC-057LZY)
      • Target: EGFR
      • Linker: MCC (4-(N-maleimidomethyl)cyclohexane-1-carboxylate)
      • Drug: doxorubicin
      Go to compare Compare
    • Anti-EGFR-EDC/NHS-Dox ADC (ADC-058LZY)
      • Target: EGFR
      • Linker: EDC/NHS(1-ethyl-3-(3-diaminopropyl)carbodiimide/N-hydroxysuccinimide)
      • Drug: doxorubicin
      Go to compare Compare
    • Anti-EGFR-SMCC-methotrexate ADC (ADC-059LZY)
      • Target: EGFR
      • Linker: SMCC (N-succinimidyl-4-(N-maleimidomethyl)-cyclohexane-1-carboxylate)
      • Drug: MTX
      Go to compare Compare
    • Anti-EGFR (J2898A)-SMCC-DM1 ADC (IMGN289) (ADC-L016)
      • Target: EGFR
      • Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
      • Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto- 1-oxopropyl)maytansine)
      Go to compare Compare
    View More Products

    Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag

    More Infomation

    Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

    For Research Use Only. Not For Clinical Use.


    Background

    HER2 is a protein encoded by the ERBB2 gene, and it is a member of the epidermal growth factor receptor (EGFR) family. It plays a crucial role in cell growth and differentiation. Overexpression or amplification of the HER2 gene is associated with several aggressive forms of cancer, most notably breast cancer. This overexpression leads to increased cell proliferation and tumor growth, making HER2 a significant target for cancer diagnostics and therapeutics. Monoclonal antibodies and small molecule inhibitors that target HER2 have significantly improved outcomes for patients with HER2-positive cancers.
    Receptor for EGF, but also for other members of the EGF family, as TGF-alpha, amphiregulin, betacellulin, heparin-binding EGF-like growth factor, GP30 and vaccinia virus growth factor. Is involved in the control of cell growth and differentiation. Phosphorylates MUC1 in breast cancer cells and increases the interaction of MUC1 with SRC and CTNNB1/beta-catenin. Isoform 2 may act as an antagonist of EGF action.
    EGFR & HER2
    Related Diseases
    Bladder Cancer Bladder Cancer
    Breast Cancer Breast Cancer
    EGFR Tyrosine Kinase Inhibitor Resistance EGFR Tyrosine Kinase Inhibitor Resistance
    Non-small Cell Lung Cancer Non-small Cell Lung Cancer
    Pancreatic Cancer Pancreatic Cancer
    Endocrine Resistance Endocrine Resistance
    Hepatocellular Carcinoma Hepatocellular Carcinoma
    Cushing Syndrome Cushing Syndrome
    Related Signaling Pathways
    JAK-STAT Signaling Pathway JAK-STAT Signaling Pathway
    Go to compare

    Go to compare

    Merry Christmas & Happy New Year
    Happy Thanksgiving close ad